Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.

[1]  P. Choyke,et al.  Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate‐specific antigen (PSA)‐based detection of prostate cancer in men without prior biopsies , 2015, BJU international.

[2]  Maarten de Rooij,et al.  Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. , 2014, European urology.

[3]  F. Schröder,et al.  Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. , 2014, European urology.

[4]  Baris Turkbey,et al.  Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy. , 2014, The Journal of urology.

[5]  C. Moore,et al.  Role of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancer , 2014, International journal of urology : official journal of the Japanese Urological Association.

[6]  P. Choyke,et al.  Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. , 2013, The Journal of urology.

[7]  Baris Turkbey,et al.  Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. , 2013, European urology.

[8]  J. Fütterer,et al.  Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. , 2013, European urology.

[9]  P. P. Iu,et al.  ESUR prostate MR guidelines. , 2013, European radiology.

[10]  Christiaan G Overduin,et al.  MRI-Guided Biopsy for Prostate Cancer Detection: A Systematic Review of Current Clinical Results , 2013, Current Urology Reports.

[11]  D Andrew Loblaw,et al.  Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. , 2010, The Journal of urology.

[12]  G. Andriole.  Image-Guided Prostate Biopsy Using Magnetic Resonance Imaging–Derived Targets: A Systematic Review: Moore CM, Robertson NL, Arsanious N, et al (Univ College London, UK; Croydon Univ Hosp, London, UK; et al) Eur Urol 63:125-140, 2013 § , 2013 .

[13]  V. Ravery,et al.  The learning curve of transrectal ultrasound-guided prostate biopsies: implications for training programs. , 2013, Urology.

[14]  Mark Emberton,et al.  Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. , 2013, European urology.

[15]  A. Jemal,et al.  International variation in prostate cancer incidence and mortality rates. , 2012, European urology.

[16]  M. Quentin,et al.  Standardisierung des multiparametrischen 3-T-MRT zur zielgerichteten Biopsie der Prostata , 2012, Der Urologe.

[17]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[18]  B. K. Park,et al.  Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy. , 2011, AJR. American journal of roentgenology.

[19]  G. Haber,et al.  Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.

[20]  B. Carey,et al.  Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.

[21]  B. G. Blijenberg,et al.  Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.

[22]  Clare Allen,et al.  Is it time to consider a role for MRI before prostate biopsy? , 2009, Nature Reviews Clinical Oncology.

[23]  S. Duffy,et al.  Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening , 2009, British Journal of Cancer.

[24]  Yousef Mazaheri,et al.  MR imaging of the prostate in clinical practice , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[25]  S. Bott,et al.  Anterior prostate cancer: is it more difficult to diagnose? , 2002, BJU international.

[26]  M. Toublanc,et al.  Extensive biopsy protocol improves the detection rate of prostate cancer. , 2000, The Journal of urology.

[27]  P. Walsh,et al.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.